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Beta cells are defined by the genes they express, many of which are specific to this cell
type, and ensure a specific set of functions. Beta cells are also defined by a set of genes
they should not express (in order to function properly), and these genes have been called
forbidden genes. Among these, the transcriptional repressor RE-1 Silencing Transcription
factor (REST) is expressed in most cells of the body, excluding most populations of
neurons, as well as pancreatic beta and alpha cells. In the cell types where it is expressed,
REST represses the expression of hundreds of genes that are crucial for both neuronal
and pancreatic endocrine function, through the recruitment of multiple transcriptional
and epigenetic co-regulators. REST targets include genes encoding transcription factors,
proteins involved in exocytosis, synaptic transmission or ion channeling, and non-coding
RNAs. REST is expressed in the progenitors of both neurons and beta cells during
development, but it is down-regulated as the cells differentiate. Although RESTmutations
and deregulation have yet to be connected to diabetes in humans, REST activation during
both development and in adult beta cells leads to diabetes in mice.
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INTRODUCTION
REST is a transcription factor that represses numerous genes that are essential to the function of
beta cells. It is thus actively excluded from beta cells andmaintains beta cell genes repressed in other
cell types. Similarly, REST is excluded from the majority of neurons, where it was first discovered,
and represses neuronal genes in other cell types. We review the discovery of REST as well as its
mechanisms of action and targets, mostly based on work with a primary focus on neurons. We
also discuss more specific work uncovering how REST repression contributes to triggering beta cell
differentiation and function.
REST, DISCOVERY AS A REPRESSOR OF NEURONAL TRAITS
In 1995, Gail Mandel and David Anderson’s groups discovered that the expression of a small
battery of genes was restricted to neurons by the recruitment in other cell types of a zinc finger
transcriptional repressor to a 21 bp DNA element (Kraner et al., 1992; Mori et al., 1992). This
repressor was called RE-1 Silencing Transcription factor (REST) because it binds to a DNA element
called repressor element-1 (RE-1) located in the rat Scn2a2 gene (Chong et al., 1995; Figure 1). In
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FIGURE 1 | REST repressor complex and activity in different cell types. Different cell types express different REST levels. Endocrine cells and neurons express
the lowest levels though some neurons can reactivate some REST transcripts at least in pathological scenarios. In all other cell types, there is some binding of REST
to its RE-1 target sequence and repressive activity, in conjunction with co-factors. The repressed targets exhibit large but not total overlap between different cell types
(with same color code as represented cells). During neuronal differentiation, REST represses neuroendocrine genes, as well as specific miRNAs that are both targets
and regulators of REST, thereby forming double negative feedback loops. Imbalanced action of positive (green arrows) and negative (red arrows) regulators of REST
stability might trigger a switch toward differentiation.
the context of the rat Stmn2 gene, it was called
Neuron-Restrictive Silencer Factor (NRSF) and its target
site was named neuron restrictive silencer element
(NRSE; Schoenherr and Anderson, 1995). These breakthrough
papers, followed by many others reporting the identification of
novel REST target genes, described a default pathway whereby
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the absence of a unique factor (REST) determines part of
the gene activity encoding fundamental traits of terminally
differentiated neurons (RE-1-containing genes). Target genes of
REST were found to be enriched in functions linked to synaptic
transmission (Schoch et al., 1996; Bessis et al., 1997; Myers et al.,
1998; Lietz et al., 2003; Bruce et al., 2004; Ballas et al., 2005),
neurotransmitter signaling (Wood et al., 1996; Bessis et al., 1997;
Bai et al., 1998; Myers et al., 1998), ion channeling (Chong et al.,
1995; Yeo et al., 2009) and specifically in humans, to learning and
memory (Rockowitz and Zheng, 2015), and to neuroprotection
and cognitive function (Lu et al., 2014). REST expression was
also found in undifferentiated neural progenitors where it
prevents precocious expression of the target genes characterizing
differentiated neurons (Chong et al., 1995; Schoenherr and
Anderson, 1995; Ballas et al., 2005; Figure 1). REST inactivation
in mice resulted in embryonic lethality starting after embryonic
day (E) 9.5 with ectopic neuronal gene expression in multiple
tissues but surprisingly not all (Chen et al., 1998).
Several observations suggest that REST can be present and
active in some neurons. Even though it is accepted that REST
expression generally decreases during neuronal differentiation
(Chong et al., 1995; Schoenherr and Anderson, 1995; Ballas et al.,
2005), REST protein (Calderone et al., 2003; Zuccato et al., 2003;
Sun et al., 2005; Gao et al., 2011; Lu et al., 2014; Schiffer et al.,
2014), and mRNA (Palm et al., 1998; Calderone et al., 2003;
Kuwabara et al., 2004; Lu et al., 2014) have been detected in
certain mature neurons, especially those of the hippocampus.
It is important to note, however, that the genuine detection
of REST has been rendered questionable mainly because of a
paucity of reliable antibodies or because of a lack of appropriate
controls. For example, discrepancies in the molecular weight of
immunoreactive bands reported as specific using western blotting
may raise several concerns.While the calculated size of REST is of
121 kDa, we, and others, have always observed it around 200 kDa,
in experiments including both negative (native beta cell lines)
and positive controls (cells overexpressing REST full length).
The numerous aspecific bands observed withmany commercially
available antibodies therefore render questionable observations
made using immunostaining without specific controls. In some
neurons, alternative splicing of REST mRNA occurs (Palm et al.,
1998), giving rise to splice variants of unclear significance such as
REST4, which possesses an inserted neuron-specific exon leading
to translational frame shift, resulting in a truncated REST protein
with four zinc fingers (Palm et al., 1998, 1999). Importantly,
disturbance of REST activity in neurons has been linked to several
human diseases, as discussed later in this review, suggesting that
the control of REST is also important for the maintenance of
neuronal function as well as for synaptic plasticity.
In non-neuronal tissues, changes in REST levels induced
by pathological conditions may provide a cellular adaptation
by affecting the expression of its targets. For example, down-
regulated REST expression upon hypertrophic stimulus triggers
the cardiac fetal gene reprogramming and correlates with
increased smoothmuscle cell proliferation in vascular neointimal
hyperplasia (Kuwahara et al., 2003; Cheong et al., 2005). In
the same spirit, it acts as a tumor suppressor in human
epithelial tissues and its de-regulation promotes tumor formation
(Westbrook et al., 2005, 2008). It is noteworthy that some of
the targets up-regulated in these pathological scenarios are also
regulated by REST in the nervous system. However, they are
in several instances regulated by REST in a cell type specific
manner. For example, NPPA is repressed by REST in cardiac
myocytes (Kuwahara et al., 2003) but not in a REST-expressing
neuronal cell line (Wood et al., 2003), while CX36 expression can
be repressed by ectopic REST expression in pancreatic beta and
alpha cell lines but not in a neuronal context (Hohl and Thiel,
2005).
The cell-specificity of REST target occupancy has been
resolved at the genome-wide level using ChIP-seq or ChIP-chip
experiments, by comparing REST regulatory networks between
embryonic stem cells (ESC) and neural stem cells (NSC; Johnson
et al., 2008), or between different neuronal and non-neuronal cell
lines (Bruce et al., 2009) and is further discussed below.
MECHANISMS OF TRANSCRIPTIONAL
REPRESSION AND EPIGENETIC
MODIFICATIONS
REST is a zinc finger protein related to members of the
Gli-Kruppel family of transcriptional repressors. The protein
contains a cluster of eight zinc fingers, which is required for
binding to the RE-1 element, and two repressor domains at the
N- and C-terminus (Figure 1). Even though a number of reports
showed that the sole ectopic expression of REST is able tomediate
target gene repression, REST activity relies on the coordinated
recruitment of multiple transcriptional and epigenetic regulators
at target loci. This combinatorial recruitment and interplay
of co-repressors and chromatin-modifying enzymes defines the
complexity and context-dependency of the regulatory landscape
controlled by REST. The N-terminus of REST recruits mSin3A
(Huang et al., 1999; Grimes et al., 2000), which serves as a
scaffold for histone deacetylases (HDACs; Huang et al., 1999;
Grimes et al., 2000). The C-terminus interacts with CoREST
(Andrés et al., 1999), which also recruits HDACs in addition
to the histone H3K4 demethylase, LSD1 (Shi et al., 2004),
the H3K9 methyltransferase, G9a (Roopra et al., 2004), the
methyl CpG binding protein MeCP2 (Lunyak et al., 2002; Ballas
et al., 2005) and BRG-1 and associated factors (Battaglioli et al.,
2002; Figure 1). Among others, reviewed in (Ooi and Wood,
2007; Qureshi and Mehler, 2009; Bithell, 2011), REST also
interacts with components or effectors of the RNA polymerase
II machinery, including the anti-neural small C-terminal domain
phosphatase 1 (CTDSP1; Yeo et al., 2005; Visvanathan et al.,
2007), Mediator subunits (Ding et al., 2009) and in human
cells with the H3K4 demethylase SMCX (Tahiliani et al., 2007)
and the corepressor C-terminal binding protein (CtBP; Garriga-
Canut et al., 2006; Figure 1). In addition, REST acts in parallel
with another key epigenetic system, the polycomb repressive
complexes (PRC), which shapes developmental stage-specific
regulatory networks by imprinting H3K27 trimethylation at
target loci. However, divergent views emerge as to whether the
two systems cooperate to drive gene repression at common loci.
REST binding motif associates with EZH2-enriched chromatin
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regions (Ku et al., 2008) and might therefore influence the
localization of PRC2-mediated chromatin marks at promoter
regions containing RE-1 motifs. However, this crosstalk was
not found to translate into transcriptional changes (Arnold
et al., 2013). Contrasted observations concluded that REST has
context-dependent functions for PRC1- and PRC2-recruitment
(Ren and Kerppola, 2011; Dietrich et al., 2012) or that
Polycomb and REST complexes direct independent epigenetic
modifications controlling early neural fate decisions vs. terminal
neural traits acquisition (McGann et al., 2014). Interestingly,
the involvement of non-coding RNAs might explain in certain
contexts how this cooperative shaping of chromatin states is
orchestrated between REST and Polycomb complexes, as it
appears that the LncRNA HOTAIR provides a scaffold for
collective recruitment of both modifying complexes at the
chromatin (Tsai et al., 2010).
REPERTOIRE OF REST-REGULATED
GENES
Identifying the repertoire of REST target loci has unraveled an
additional level of complexity in the mechanisms dictated by
REST to generate cell type-specific and developmental stage-
specific gene activity programs (Bithell, 2011). The unusual
length of the RE-1 motif has allowed in silico identification
of putative REST targets across human and murine genomes
(Bruce et al., 2004; Mortazavi et al., 2006; Wu and Xie,
2006) and accession to deep-sequencing-associated chromatin
immunoprecipitation (ChIP) techniques has increased the
number of genes expected to be under REST regulation to the
scale of several thousands (Johnson et al., 2007; Otto et al., 2007;
Bruce et al., 2009; Rockowitz and Zheng, 2015).
By comparing chromatin occupancy, chromatin
modifications, and gene expression in various neuronal
and non-neuronal cell types, several studies have provided novel
findings. They reveal the existence of different combinations
of RE-1 half sites, resulting in a variety of non-canonical RE-1
motifs with varying binding affinities for REST (Otto et al., 2007).
Few REST targets were ascribed to non-neuronal functions, such
as immune/inflammatory response and cell adhesion, suggesting
that REST may not merely be a repressor of neuronal traits (Otto
et al., 2007). Another study shows that the number of bound
targets decreases as neurons differentiate: among all the targets
bound in ESCs and NSCs, 45% are solely bound in ESCs while
50% are shared, and very few are specifically bound in NSC
(Figure 1). Many of the ESC-specific REST targets are involved
in pluripotency and are commonly targeted by key pluripotency
factors OCT4, NANOG, and SOX2, including Nanog itself
(Johnson et al., 2008). Therefore, REST appears to form an
autoregulatory circuit which is connected to the autoregulatory
circuit of pluripotency factors. Activating and repressive
transcriptional signals thus control ESC pluripotency. When
comparing eight neuronal and non-neuronal cell lines, 90%
of all REST targets show cell-specificity in REST recruitment.
The level of REST protein and the sequence variations in the
RE-1 motif govern this modular association of REST to its
repertoire of target loci across the different lines (Bruce et al.,
2009). REST directly down-regulates a large number of genes at
the transcriptional level, but also probably indirectly activates
the expression of other genes at the post-transcriptional level
via the repression of many noncoding targets (Conaco et al.,
2006; Mortazavi et al., 2006; Wu and Xie, 2006; Visvanathan
et al., 2007; Singh et al., 2008; Johnson et al., 2009), including
several micro RNAs (miRNAs) considered to be brain-specific
(such as miR9, miR124, miR132, miR135, miR139, and miR153;
Figure 1). Importantly, REST itself appears to be a predicted
target of miR-153 (Mortazavi et al., 2006; Wu and Xie, 2006),
miR-9 and miR-29a (Wu and Xie, 2006). Furthermore, miR-124
and other neuronal-specific miRNAs target various components
of the REST complex, including CTDSP1 and CoREST (Xue
et al., 2013). Together, these reports describe a double-negative
feedback loop between REST and brain-related miRNAs in
controlling neuronal gene expression.
Altogether, these reports integrating transcriptomic and
epigenomic data have contributed to a great extent toward
the deciphering of the complex mechanisms by which REST
shapes regulatory landscapes and controls gene expression in a
developmental stage- and cell-specific manner.
REST IS DISALLOWED FOR NORMAL
ADULT PANCREATIC BETA CELL
FUNCTION AND MAINTENANCE
Pancreatic beta cells and neurons are derived from different
germ layers, the endoderm and ectoderm layers, respectively,
yet they share a large number of functional similarities. Beta
cells and neurons are both electrically excitable and respond to
hormonal stimuli and glucose by depolarization and exocytosis
in a process similar to neurotransmitter release. At the molecular
level, there are many overlapping patterns of gene expression
between the two cell types (van Arensbergen et al., 2010). The
shared proteins include enzymes implicated in the synthesis of
neurotransmitters, receptors for growth factors and amino acids,
neurofilaments, hormones (Atouf et al., 1997), proteins involved
in the machinery of exocytosis of synaptic vesicles (Burgoyne
and Morgan, 2003), and many transcription factors such as
NEUROD/BETA2 (Naya et al., 1995). In 1997, the group of
Scharfmann was the first to suggest that, in addition to sharing
common transactivators, beta cell lines and neurons are devoid
of REST expression. This enables the expression of important
functional genes harboring RE-1 motifs including the N-methyl-
D-aspartate (NMDA) receptor, the dopamine β-hydroxylase,
Scg10, Synapsin, and the nicotinic acetylcholine receptor β2
subunit (Atouf et al., 1997; Figure 2). The list of REST-regulated
genes expressed in beta cells was further extended with the
characterization of RE-1 motifs associated with Mapk8ip1/Ib1
and Gjd2/Cx36 (Abderrahmani et al., 2001, 2004; Martin et al.,
2003). MAPK8iP1, identified as a genetic factor associated with
type 2 diabetes (Waeber et al., 2000), is a scaffold protein that
protects beta cells against apoptosis via the interaction with the c-
Jun N-terminal kinase (JNK) signaling pathway (Haefliger et al.,
2003) and GJD2, a gap junction-forming protein that controls
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FIGURE 2 | Processes and specific genes regulated by REST in beta cells. REST regulates multiple functional processes (boxes) in beta cells. Some
non-exhaustive examples of genes and encoded proteins regulated by REST are shown in red. Several of these genes are regulated by REST not only in the functional
adult beta cell but also during development. Dotted lines indicate a hypothetical or indirect link. The question mark next to REST indicates that although REST
re-expression in beta cells in physiological or pathological conditions was not reported, its re-expression in neurons suggests this may be expected.
insulin secretion via cell to cell communication (Haefliger et al.,
2003; Head et al., 2012).
Using qPCR and Western blot, we showed that REST was
also excluded from adult primary beta cells in mice (Martin
et al., 2008, 2015). Importantly, while there are concerns about
the specificity of available antibodies (as discussed above in
the context of neurons), we provided a western blot analysis
including bona fide negative (native beta cell line extracts) and
positive controls (beta cells overexpressing murine REST). This
allowed to identify the correct immunoreactive band and to
unequivocally demonstrate the absence or extremely low levels of
production of REST in murine islet cells. Previous transcriptome
studies of the pancreas using next generation sequencing on
whole islets or purified islet cells showed no or insignificant levels
of Rest expression in mouse (Ku et al., 2012; Benner et al., 2014)
and in human endocrine pancreas (Nica et al., 2013; Blodgett
et al., 2015). The advent of single-cell transcriptomic analyses
coupled to unbiased in silico identification of different cell types
recently reaffirmed the concept that Rest is expressed in duct and
in acinar cells, while totally absent from human endocrine cell
types (Li et al., 2016; Muraro et al., 2016; Segerstolpe et al., 2016).
We investigated the functional importance of REST target genes
in pancreatic beta cells by ectopic expression of REST in beta
cells using RIP-REST transgenic mice. REST mis-expression in
beta cells led to impaired glucose homeostasis due to a decrease
in both phases of glucose-stimulated insulin secretion. Several
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defects were noticed that likely accounted for this depressed
insulin release: (1) pancreatic insulin content was decreased by
half in RIP-REST mice, (2) beta cell counts were 30% lower
than in control mice, (3) a selective battery of genes involved in
exocytosis of large dense core vesicles, including Snap25, Syt4,
Syt7, Syt9, and Cplx2 were under the control of functional RE-
1 motif and were down-regulated (Martin et al., 2008; Figure 2).
Altogether, our results indicated that besides their implication
in insulin secretion, a subset of the RE-1-containing genes may
be important for beta-cell turnover. This was confirmed in
another line of RIP-REST animals featuring higher levels of
REST transgene expression, which developed diabetes due to
a dramatic loss in beta-cell mass. Genes relevant to beta cell
survival were also found to be under REST control in vivo,
including Gjd2, Ib1, Ptprn, and Cdk5r2 (Martin et al., 2012;
Figure 2). Because of the wide range of naturally occurring
combinations of RE-1 half sites in the genome (see above), it is
likely that greater expression of REST led to a greater number of
bound genes, especially those bearing non-canonical RE-1 motif
with suboptimal binding affinity. Mis-expression in adult beta
cells using an inducible transgene PDX-tTA; TetO-REST also
led to diabetes, as a combined effect of REST mis-expression
over both differentiation and maintenance of beta cells
(Martin et al., 2015).
Taken together, our work and others’ (reviewed in Thiel et al.,
2015) show that REST activity needs to be repressed in adult beta
cells, qualifying REST as a so-called “disallowed/forbidden” gene
(Quintens et al., 2008; Pullen and Rutter, 2013; Lemaire et al.,
2016). This classification, however, might be tempered by the fact
that the strict definition would imply that Rest shows its lowest
level of expression in pancreatic beta cells as compared to all
other cell types. REST is also absent in other pancreatic endocrine
cells as well as most neurons and does thus not strictly qualify the
definition. We may need to categorize such genes if they become
more numerous. Comprehensive analysis of the chromatin and
transcriptional modifications triggered by the mis-expression of
REST in adult beta cells would provide valuable insights into the
number and role of all REST-controlled genes that constitute this
beta-cell-specific sub-signature.
ROLE OF REST IN BETA CELL
DEVELOPMENT
The exclusion of REST from beta cells (Atouf et al., 1997;
Martin et al., 2008), the role of REST as a gatekeeper
of neuronal differentiation (Ballas et al., 2005; Gao et al.,
2011; Mao et al., 2011; Xue et al., 2013; Love and Prince,
2015) and the similarities between neuron and endocrine cell
differentiation suggested that REST may also restrict endocrine
cell differentiation during development. Accordingly, we found
that REST is expressed in progenitors, and is down-regulated
in differentiating alpha and beta cells during development
(Martin et al., 2015). Several lines of evidence suggest that
REST is repressed already in NEUROG3+ endocrine precursors
(Figure 3). First, Rest transcript is decreased 5.8 times more
in beta cells emerging from NEUROG3+ precursors than
in young NEUROG3+ cells (http://www.betacell.org/resources/
data/studies/view/study_id/3100 and ArrayExpress E-CBIL-48)
(Soyer et al., 2010). Second, transcriptome analysis after
NEUROG3 in vivo gain-of-function at E11.25 (Johansson et al.,
2007) shows a 1.9 fold decrease of Rest in the pancreatic bud after
NEUROG3 over-expression (http://www.betacell.org/resources/
data/studies/view/study_id/3733) (Cortijo et al., 2012). The Rest
gene acquires a Polycomb-mediated H3K27me3 repressive mark
after the pancreatic progenitor stage, which can be interpreted
as an outcome of the repression of REST expression and/or
as a mechanism that ensures its repression (van Arensbergen
et al., 2010). ChIP sequencing analysis has detected several REST
binding sites in the vicinity of genes that promote endocrine
development such as NeuroD, Neurog3, Onecut1, or Hnf4α
(Johnson et al., 2007), which suggests that REST in progenitors
represses endocrine differentiation (Figure 3). Hence, gain-of-
function in pancreatic progenitors using the inducible transgenic
line PDX-tTA; TetO-REST (Martin et al., 2015) severely decreases
the formation of NEUROG3+ precursors and of differentiated
endocrine cells. Moreover, conditional inactivation of REST
in pancreas progenitors inhibits the expression of important
factors of endocrine differentiation, leading to the formation
of endocrine cells in appropriate numbers but in a partially
differentiated state. The observation that REST depletion is not
sufficient to fully promote endocrine cell formation suggests
that there are multiple gates in the differentiation, and that
either other repressors or activators are acting parallel to REST.
The control over a subprogram is in agreement with what was
observed in the context of neuronal differentiation in Rest-
deficient mice (Aoki et al., 2012) and zebrafish (Kok et al., 2012).
In the neural retina, Rest deletion in ganglion progenitor cells
led to an increased number of retinal ganglion cells, via the
up-regulation of crucial regulators of this cell type (Mao et al.,
2011). A change in differentiation can be difficult to detect if
complex feedback mechanisms are involved. For example, in the
adult brain, loss of REST only triggers a transient increase in
neurogenesis and depletion of the hippocampal stem cells (Gao
et al., 2011).
In the pancreas, NEUROG3, which appears to be a direct
target of REST by Chip-Seq is not induced in the knock-out
and may be independently repressed by HES1 (Jensen et al.,
2000; Figure 3). It is also possible that, in spite of REST binding
NEUROG3 regulatory sequences, the chromatin at this locus
may not be poised to activation. This scheme is suggested
by the observation that REST and Polycomb repressions act
in parallel in neuronal differentiation (McGann et al., 2014)
as well as in pancreatic beta-cells (van Arensbergen et al.,
2010). Indeed, in pancreatic progenitors, PcG marks a wide
number of disallowed genes for beta cells, including regulators
of alternate developmental fate that will never be activated in
the differentiation path, while REST binds in ES cells to genes
in which PcG repression disappears in beta cells (Figure 3).
The targets activated upon REST depletion are expected
to affect a variety of functions including transcription factors
that control differentiation (Onecut1, Onecut2, Hnf4a, Myt1,
Arx, Neurod1, Mafb), proteins acting in insulin maturation
(Pcsk1, Pcsk2), insulin secretion (Chga, Chgb, Syt4), cell
Frontiers in Cell and Developmental Biology | www.frontiersin.org 6 February 2017 | Volume 5 | Article 12
Martin and Grapin-Botton Disallowed REST in Beta Cells
FIGURE 3 | REST regulation and activity in the differentiation from pancreas progenitors to endocrine cells. The top panel shows the level of REST/REST
activity in the endocrine lineage (red is high, orange medium, and yellow low/absent). REST levels are paralleled by polycomb (PcG) and the Notch target gene HES1.
As these transcripts decrease, there is a transient peak of NEUROG3 as progenitors differentiate into endocrine progenitors. The endocrine cells derived from them
exhibit low/absent expression of all four. There are multiple parallel blocks on endocrine differentiation by HES1, REST, and PCG at two stages of differentiation, firstly
in the progression to endocrine precursors and secondly in their further differentiation into endocrine cells. How endocrine progenitors escape the multiple block to
turn on NEUROG3 is unclear. NEUROG3 then promotes the differentiation program. The interactions between REST, HES1, and PCG remain to be deciphered at the
level of targets and on their own regulatory sequences.
to cell communication (Gjd2, Mfng), anti-apoptotic activity
(Ptprn, Cdk5r2) and differentiation functions (Celsr3; Figure 3).
Although the subset of REST targets in the pancreas containing
Celsr3 (Jia et al., 2014) and Syt4 is also under REST repression
in the nervous system, many targets are specific to one or the
other tissue, suggesting that transcriptional repression by REST
functions in a cell type-specific manner, as discussed above.
This may be accounted for by the level of REST protein, the
sequence variations in the RE-1 motif or the presence of co-
factors (Johnson et al., 2008; Bruce et al., 2009).
REST DOWN-REGULATION AS A SWITCH
FOR NEURONAL AND ENDOCRINE
DIFFERENTIATION
The examples discussed above illustrate how a tight regulation of
REST leads to its expression inmost cells and its general exclusion
from beta cells and neurons. The mechanisms regulating REST
during normal development, adult life and pathological scenarios
are still largely enigmatic. Three promoters, six enhancers and
two repressor regions with differences of activity in different cell
types regulate REST transcription but the transcription factors
regulating their activity are unclear (Koenigsberger et al., 2000).
The REST gene contains several RE-1 sites, indicating a putative
negative autoregulatory feedback on its own expression (Johnson
et al., 2007, 2008).
REST is down-regulated as neurons or pancreatic endocrine
cells differentiate, but what triggers this is unclear. In the
pancreas, it is accompanied by the acquisition of an epigenetic
PcG-mediated H3K27me3 repressive mark occurring after the
pancreatic progenitor stage, which coincides with the activation
of a core beta-cell derepression program (van Arensbergen et al.,
2010). During ES cell differentiation into cortical neurons, most
of the regulation is initially post-transcriptional while REST
transcription is eventually decreased (Ballas et al., 2005). REST
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abundance and stability are influenced by coordinated kinase,
phosphatase, and ubiquitin ligase activities. On the one hand, the
CTDSP1 phosphatase activity targets a phosphorylation site in
REST and stabilizes it in stem cells. (Yeo et al., 2005; Figure 1).
On the other hand, because CTDSP1 expression decreases with
differentiation (Visvanathan et al., 2007), the ERK-dependent
phosphorylation at the same site, together with the peptidylprolyl
isomerase Pin1 activity, promote REST degradation in neural
progenitors (Nesti et al., 2014). It appears that phosphorylation
of the motif allows recruitment of SCFβTRCP, an E3 ubiquitin
ligase that is induced during neuronal differentiation and is
responsible for REST degradation and subsequent neuronal
differentiation (Westbrook et al., 2008). Decreased expression
of the deubiquitylase HAUSP during neuronal differentiation
further destabilizes REST (Huang et al., 2011). The activity of
the REST repressive complex during neuronal differentiation is
also tightly controlled at the transcriptional level, and includes
a HDAC-dependent regulation triggered by retinoic acid (Ballas
et al., 2005). However, the most documented mechanism is post-
transcriptional and involves a double negative feedback loop
involving miRNAs. REST regulates the expression of miRNAs
and is itself regulated by them, including miR-153 (Mortazavi
et al., 2006; Wu and Xie, 2006), miR-9 and miR-29a (Wu
and Xie, 2006; Figure 1). miR-124, another component of this
double feedback loop, has reciprocal activity by inhibiting non
neuronal transcripts (Conaco et al., 2006). REST represses miR-
124, an miRNA that targets various REST components including
CTDSP1 and CoREST (Xue et al., 2013). This system of large
autoregulatory loops is controlled by another feedforward loop
that involves the polypyrimidine-tract-binding (PTBP1) protein,
which secures this system by competing at miR-124 targets (Xue
et al., 2013; Figure 1).
It would be of interest to identify which signals, in addition to
that directed by PcG complex, dictate REST extinction along the
pancreatic developmental pathway.
UP-REGULATION OF REST ACTIVITY IN
NEURONS PROMOTES NEUROLOGICAL
DISEASES. COULD PATHOLOGICAL REST
ACTIVATION TRIGGER BETA CELL
FAILURE?
Several studies have documented that aberrant induction of
REST expression in neurons or progenitors plays a role
in neurodegenerative and neurodevelopmental diseases. The
example studied in most depth is Rett syndrome, which is a
neurodevelopmental disorder caused by mutations in the methyl
CpG binding protein 2 gene (MeCP2). This causes an increase
in expression of REST and CoREST, and as a consequence the
downregulation of their target BDNF (Abuhatzira et al., 2007)
and neuron-specific K(+)-Cl(−) cotransporter2 (KCC2; Tang
et al., 2016). A few cases of type 1 diabetes have been associated
to Rett syndrome, but the number of cases is still too low to
determine whether this is mere serendipity or if they were caused
by MeCP2 mutations and downstream REST activity (Kurtoglu
et al., 2005; Rekik et al., 2010; Akin et al., 2012). De-repression
of REST in neurons has also been shown to occur in response
to ischemia, leading to down-regulation of REST target genes,
notably the GRIA2 subunit of the glutamate receptor regulating
Ca2+ permeability and miR-29c, that promoted neuronal death
(Calderone et al., 2003; Noh et al., 2012; Pandi et al., 2013).
Kainic acid, a glutamate analog also promotes REST expression
but it is unclear whether this occurs at physiological levels to
modulate neuronal function or only upon massive glutamate
release (Palm et al., 1998). REST activation has also been reported
in the brain of Huntington’s disease patients and involves a
cytoplasmic sequestering of REST by wild type huntingtin, which
is lost with themutant protein (Zuccato et al., 2003, 2007; Schiffer
et al., 2014). Increased REST activity in neurons or progenitor
cells is also associated with Down syndrome (Bahn et al., 2002;
Lepagnol-Bestel et al., 2009).
Up-regulation of Rest mRNA and protein is also a
prominent feature of a subset of human glioblastomas and
medulloblastomas (Lawinger et al., 2000; Su et al., 2006; Conti
et al., 2012; Kamal et al., 2012; Wagoner and Roopra, 2012).
These pediatric malignant brain tumors are thought to arise
from undifferentiated neural progenitors, and REST may be
promoting tumor formation by preventing their differentiation
(Su et al., 2006). However, the mechanism underlying REST
induction in these tumors remains unknown.
REST induction in the brain may not always be detrimental.
REST is promoted by BMPs during astrocyte differentiation from
progenitors and is likely to enforce programs divergent from their
neuronal sister cells (Kohyama et al., 2010). This appears to be
direct and is mediated by a smad-binding site in REST promoter,
but whether BMP also promotes REST in other contexts remains
to be explored. In addition, it has been proposed thatWnt-driven
REST expression increases in aging neurons of the cortex and
hippocampus and may play a protective role against Alzheimer’s
disease and fronto-temporal dementia (Lu et al., 2014).
REST expression is forbidden in pancreatic endocrine cells
and violation of this disallowance can provoke diabetes in mice
(Martin et al., 2012, 2015). Its up-regulation in humans may
also cause or contribute to type 2 diabetes, neonatal diabetes, or
maturity onset diabetes of the young. The latter two are caused
by mutations in one gene, usually key to pancreatic endocrine
development or beta cell biology. Though REST gain-of-function
mutations have not yet been reported as causes of monogenic
diabetes, the 22 known mutations account for 80% of cases (De
Franco et al., 2015). About 20% of the cases therefore remain of
unknown genetic etiology.
REST REPRESSION AS A TOOL FOR
REPROGRAMMING CELLS INTO
NEURONS OR ENDOCRINE CELLS
Elucidating the role of REST in development and lineage
specification uncovered new roles for this factor in embryonic
stem cell (ESC) pluripotency. REST is expressed at high levels
in mouse ESC (Ballas et al., 2005) and a series of genome-wide
analyses demonstrated that in both mouse and human ESC,
REST is a target and partner of multiple factors controlling
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pluripotency, including NANOG, OCT4, and SOX2 (Boyer et al.,
2005; Loh et al., 2006; Wang et al., 2006; Kim et al., 2008).
Moreover, a subset of the REST regulatory network is shared with
these three factors (Johnson et al., 2008). However, the role of
REST as a pluripotency factor remains controversial. Although
loss of REST in mouse ESC may decrease the expression of
pluripotency factors and their self-renewal capacity via activation
of miR-21 (Singh et al., 2008, 2012, 2015), other reports showed
that REST loss-of-function did not restrict ESC self-renewal or
their multiple lineage potential (Buckley et al., 2009; Jørgensen
et al., 2009; Yamada et al., 2010). REST may be important,
however, for proper timing and acquisition of the primitive
endodermal fate by repressing NANOG (Johnson et al., 2008;
Yamada et al., 2010).
Recent evidence suggests that depleting non-neuronal cells
of REST can promote reprogramming. Fresh mouse cortical
astrocytes can be reprogrammed into neurons when transduced
with ASCL1 or NEUROG2. However, the conversion of
astrocytes cultured for several days is possible only with the
inactivation of REST and the activation of either ASCL1 or
NEUROG2. Prolonged culture increases the level of H4K20me3
at the NeuroD4 promoter, a key reprogramming factor, and
promotes a local chromatin environment favorable to the
repressive complex REST. In these conditions REST outcompetes
NEUROG2 in terms of binding to the NeuroD4 promoter
(Masserdotti et al., 2015).
It is not clear whether this change in chromatin at REST loci
upon culture is a general principle andwhether it can be exploited
to reprogram other cell types. Genetic inactivation of REST does
not efficiently turn fibroblasts into neurons despite the induction
of some neuronal genes, suggesting that additional epigenetic or
transcription factors are required (Aoki et al., 2012). A similar
strategy applied to generate reprogrammed beta cells had very
limited success. Indeed, forced expression of ShRest/Nrsf, shShh,
and PDX1 in bone marrow-derived mesenchymal stem cells
induces several markers of beta cells including insulin, but to
<10 fold, which is minimal since these cells express very low
levels of beta cell genes (Li et al., 2012). However, shREST was
able to trigger neuronal differentiation from MEFs, potentially
via a feedforward loop that involves PTBP1 and miR-124 (Xue
et al., 2013). Whether the same paradigm applies to humans is
unclear (Xue et al., 2016). In these attempts, one must bear in
mind that depleting REST from a cell that does express it may
have detrimental effects. A recent model of REST inactivation
in neuronal progenitors shows that the absence of REST in
proliferative cells that normally express it leads to DNA damage
(Nechiporuk et al., 2016). If the affected cells are prevented
from dying by p53 inactivation, some develop glioblastoma and
primitive neuroectodermal tumor.
Despite the relatively large amount of information regarding
the importance of REST in the regulation of the neuronal lineage,
the study of REST vis-a-vis endocrine differentiation and beta
cell function is in its infancy. Proof of concepts have established
that REST must be excluded from beta cells but a global view of
its regulation and targets during differentiation, in the embryo,
in the early post-natal cells, during aging and in pathological
processes is missing. Although it is becoming clear that REST
is absent in human pancreatic endocrine cells, a tally of genes
regulated by REST would be valuable, as well as information
on its expression and role in other endocrine lineages in the
intestine. Finally, most research has been restricted to mice but
its targets in the human endocrine lineage and its role in diabetes
will eventually be of utmost interest.
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